1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. NEUROREHABILITATION DEVICES MARKET BY TYPE
5.1. Introduction
5.2. Neurorobotic Systems
5.3. Brain-Computer Interfaces
5.4. Wearable Devices
5.5. Non-Invasive Stimulators
5.6. Neurorehabilitation Gaming Systems
5.7. Others
6. NEUROREHABILITATION DEVICES MARKET BY APPLICATION
6.1. Introduction
6.2. Stroke
6.3. Spinal Cord Injury
6.4. Traumatic Brain Injury
6.5. Parkinson's Disease
6.6. Cerebral Palsy
6.7. Others
7. NEUROREHABILITATION DEVICES MARKET BY END-USER
7.1. Introduction
7.2. Hospitals
7.3. Clinics
7.4. Rehabilitation Centers
7.5. Home Care Settings
8. NEUROREHABILITATION DEVICES MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Medtronic plc
10.2. Abbott Laboratories
10.3. Ekso Bionics Holdings, Inc.
10.4. Bionik Laboratories Corp.
10.5. St. Jude Medical (a subsidiary of Abbott Laboratories)
10.6. Hocoma AG (a subsidiary of DIH International Limited)
10.7. ReWalk Robotics Ltd.
10.8. Tyromotion GmbH
10.9. Kinova Robotics
10.10. Reha-Stim Medtec GmbH & Co. KG
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES